← Back to Brands

Blod NOSDA

Community footprint analysis based on portfolio size and patient feedback.

Time Period:
Rank
20
Portfolio
1 Strain
Mentions (90d)
6
Brand Score (90d)
68
vs Market Avg: 65 vs All Time: 65
Performing Well

Rating higher than the 90d community baseline.

Medication Portfolio (1)

Rank Strain Name Specs Mentions (90d) Score (90d) Historical Avg
199
26.0%
6
68
65